
Overview
Laven is a company that offers group health insurance for businesses, providing employees with access to modern medical therapies, specialist consultations, and treatment financing up to 4 million PLN. Their services include coverage for advanced medical procedures, second medical opinions from over 100 prestigious clinics worldwide, and financial support for modern prosthetics. They offer basic and extended insurance packages starting from 40 PLN per month, ensuring comprehensive health support for employees.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 115 days for 2023). All were audited by a statutory auditor.
- 2025not filed
- 202418/07/2025
- 202307/11/2024
- 202215/07/2023
- 202107/10/2022
- 202006/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Offer
- Group health insurance
- Modern medical technologies
- Medical opinions
- Prosthesis financing
- Medical consultations
Websites
- laven.plLaven | Grupowe ubezpieczenie zdrowotne – Pełna ochrona już od 40 PLN miesięcznieWebflowMeta PixelLLiteSpeed
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2021.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Laven Najwyższa jakość leczenia | Z.526839 | 36 | Protected | Mar 29, 2031 |
| Mark | Protected until | |
|---|---|---|
| Laven Najwyższa jakość leczenia | Mar 29, 2031 |
Authorized Representatives
Manner of representation
For making declarations of will (representation) on behalf of the company, joint action of three members of the management board or of the President of the Management Board acting jointly with another member of the management board is required.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Meritum L.A. sp. z o.o. | 137,817.40 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2021-01-01.
31 1050 1575 1000 0090 8133 1150
87 1050 1575 1000 0090 3222 8257
43 1050 1575 1000 0090 3222 8273
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 26, 2021 | Commercial Companies Code notice | |
| Dec 28, 2020 | Commercial Companies Code notice | |
| Nov 25, 2020 | Commercial Companies Code notice | |
| Oct 28, 2020 | Commercial Companies Code notice | |
| Oct 1, 2020 | Commercial Companies Code notice |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 25, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $466$466 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 17, 2021 | Aid for SME access to finance — aid for start-ups | $119.8K$119,844 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Benefit Consulting sp. z o.o. | $875,354.05 | bca.com.pl | ||
| Kodar Polska sp. z o.o. | $441,780.91 | kodar.pl | ||
| Rkrisk sp. z o.o. | $415,407.07 | rkrisk.pl | ||
| Projekt Polisa sp. z o.o. | $381,511.92 | projektpolisa.pl | ||
| Domubezpieczeniowy.Com sp. z o.o. | $368,953.79 | domubezpieczeniowy.com | ||
| Barscy Ubezpieczenia sp. z o.o. | $279,037.19 | barscyubezpieczenia.pl | ||
| Philotimo sp. z o.o. | $268,398.84 | onkopolisa.pl | ||
| Team Broker sp. z o.o. | $193,035.24 | teambroker.pl | ||
| UNI Plus sp. z o.o. | $185,065.26 | uniplus.pl | ||
| DF Finanse sp. z o.o. | $154,472.63 | dfinanse.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-06-15 | Share capital increase (115,706.00 PLN → 130,479.20 PLN) | |
| 2022-06-15 | PKD change (Removed: 46.18.Z) | |
| 2022-02-21 | Share capital increase (112,836.40 PLN → 115,706.00 PLN) | |
| 2022-01-19 | Share capital increase (109,451.30 PLN → 112,836.40 PLN) | |
| 2021-12-06 | Share capital increase (104,712.00 PLN → 109,451.30 PLN) |
FAQ
Last updated: 2026-11-03